Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 2
2012 1
2013 3
2014 2
2015 1
2016 2
2017 1
2018 3
2019 2
2020 1
2021 2
2022 5
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Calcineurin Inhibitor - Induced Nephropathy"
Page 1
Immunosuppressive treatment for proliferative lupus nephritis.
Tunnicliffe DJ, Palmer SC, Henderson L, Masson P, Craig JC, Tong A, Singh-Grewal D, Flanc RS, Roberts MA, Webster AC, Strippoli GF. Tunnicliffe DJ, et al. Cochrane Database Syst Rev. 2018 Jun 29;6(6):CD002922. doi: 10.1002/14651858.CD002922.pub4. Cochrane Database Syst Rev. 2018. PMID: 29957821 Free PMC article. Review.
BACKGROUND: Cyclophosphamide, in combination with corticosteroids, has been first-line treatment for inducing disease remission for proliferative lupus nephritis, reducing death at five years from over 50% in the 1950s and 1960s to less than 10% in recent years. Several tr …
BACKGROUND: Cyclophosphamide, in combination with corticosteroids, has been first-line treatment for inducing disease remission for p …
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
von Groote TC, Williams G, Au EH, Chen Y, Mathew AT, Hodson EM, Tunnicliffe DJ. von Groote TC, et al. Cochrane Database Syst Rev. 2021 Nov 15;11(11):CD004293. doi: 10.1002/14651858.CD004293.pub4. Cochrane Database Syst Rev. 2021. PMID: 34778952 Free PMC article. Review.
Oral alkylating agents with or without steroids had uncertain effects on infection and malignancy. Calcineurin inhibitors (CNI) with or without steroids versus placebo/no treatment/supportive therapy/steroids We are uncertain whether CNI with or without steroids inc …
Oral alkylating agents with or without steroids had uncertain effects on infection and malignancy. Calcineurin inhibitors (CNI …
Interventions for minimal change disease in adults with nephrotic syndrome.
Azukaitis K, Palmer SC, Strippoli GF, Hodson EM. Azukaitis K, et al. Cochrane Database Syst Rev. 2022 Mar 1;3(3):CD001537. doi: 10.1002/14651858.CD001537.pub5. Cochrane Database Syst Rev. 2022. PMID: 35230699 Free PMC article. Review.
OBJECTIVES: We aimed to 1) evaluate the benefits and harms of different agents, including both immunosuppressive and non-immunosuppressive agents, in adults with MCD causing the nephrotic syndrome; and 2) evaluate the efficacy of interventions on 'time-to-remission' of nephrotic …
OBJECTIVES: We aimed to 1) evaluate the benefits and harms of different agents, including both immunosuppressive and non-immunosuppressive a …
Risk factors for calcineurin inhibitor nephrotoxicity after renal transplantation: a systematic review and meta-analysis.
Xia T, Zhu S, Wen Y, Gao S, Li M, Tao X, Zhang F, Chen W. Xia T, et al. Drug Des Devel Ther. 2018 Feb 28;12:417-428. doi: 10.2147/DDDT.S149340. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 29535503 Free PMC article. Review.
BACKGROUND: Nephrotoxicity of calcineurin inhibitors (CNIs) is the major concern for long-term allograft survival despite its predominant role in current immunosuppressive regime after renal transplantation. ...
BACKGROUND: Nephrotoxicity of calcineurin inhibitors (CNIs) is the major concern for long-term allograft survival despite its …
Immunosuppression therapy for idiopathic membranous nephropathy: systematic review with network meta-analysis.
Bose B, Chung EYM, Hong R, Strippoli GFM, Johnson DW, Yang WL, Badve SV, Palmer SC. Bose B, et al. J Nephrol. 2022 May;35(4):1159-1170. doi: 10.1007/s40620-022-01268-2. Epub 2022 Feb 23. J Nephrol. 2022. PMID: 35199314 Free PMC article.
BACKGROUND: Idiopathic membranous nephropathy is a common cause of nephrotic syndrome in adults. The Kidney Disease Improving Global Outcomes guidelines recommend rituximab or cyclophosphamide and steroids, or calcineurin inhibitor-based therapy. ...Cy …
BACKGROUND: Idiopathic membranous nephropathy is a common cause of nephrotic syndrome in adults. The Kidney Disease Improving …
Tacrolimus use in lupus nephritis: A systematic review and meta-analysis.
Hannah J, Casian A, D'Cruz D. Hannah J, et al. Autoimmun Rev. 2016 Jan;15(1):93-101. doi: 10.1016/j.autrev.2015.09.006. Epub 2015 Sep 30. Autoimmun Rev. 2016. PMID: 26427983 Review.
The meta-analysis showed that overall tacrolimus is more effective at inducing complete renal remission than IVCYC (p=0.004), but there is no significant difference compared to MMF (p=0.87). ...
The meta-analysis showed that overall tacrolimus is more effective at inducing complete renal remission than IVCYC (p=0.004), but the …
Treatment of Idiopathic Membranous Nephropathy for Moderate or Severe Proteinuria: A Systematic Review and Network Meta-Analysis.
Chen M, Liu J, Xiong Y, Xu G. Chen M, et al. Int J Clin Pract. 2022 Apr 23;2022:4996239. doi: 10.1155/2022/4996239. eCollection 2022. Int J Clin Pract. 2022. PMID: 35685506 Free PMC article. Review.
OBJECTIVE: Numerous studies have demonstrated that the efficacy of drugs differs in idiopathic membranous nephropathy (IMN) patients with moderate or high proteinuria. However, there is no systematic comparison confirming it. ...Rituximab (RTX) was more beneficial for TR o …
OBJECTIVE: Numerous studies have demonstrated that the efficacy of drugs differs in idiopathic membranous nephropathy (IMN) patients …
The efficacy of immunosuppressive drugs induction therapy for lupus nephritis: a systematic review and network meta-analysis.
Dong Y, Shi J, Wang S, Liu Y, Yu S, Zhao L. Dong Y, et al. Ren Fail. 2023;45(2):2290365. doi: 10.1080/0886022X.2023.2290365. Epub 2023 Dec 12. Ren Fail. 2023. PMID: 38087473 Free PMC article. Review.
METHODS: A systematic review and network meta-analysis (NMA) was conducted on randomized controlled trials investigating the efficacy of immunosuppressant-induced therapy for LN. The random effects model was used in the analysis. ...
METHODS: A systematic review and network meta-analysis (NMA) was conducted on randomized controlled trials investigating the efficacy of imm …
27 results